??12 Moreover, some devices such as the AngioJet device (Possis Medical, Inc., Minneapolis, MN, USA) have been shown to increase the adverse cardiac events.13 One explanation why clinical outcome data with adjunctive devices is currently unknown is that individual trials have been powered to study only the surrogate markers of clinical outcomes, such as the Thrombolysis In Myocardial Infarction (T